$AIDX

$0.23 -$0.00 (1.15%) Close

$AIDX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 12.8M shares outstanding

Who owns AIDX?

By type of holder

Institutions 4.2% Insiders 11.1% Everyone else 84.7%

Concentration Top 10 holders own 18.7%

Jonathan M Cohen 14.4% · Cresset Asset Management, LLC 1.9%

Institutional ownership

4.2%

+1.8 pts vs last qtr

Institutional holders

+7 vs last qtr

Net shares bought

+230.2K

by institutions in Q2 2026

New / sold out

9 / 2

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

HRT Financial LP NEW +89.3K
Vanguard Fiduciary Trust Co NEW +52.1K

Biggest sellers in Q2 2026

Cresset Asset Management, LLC −24.2K
XTX Topco Ltd SOLD OUT −10.3K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for 20/20 Biolabs Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025

+2.7%

+2.70% a year

Each share's claim on the business

−2.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $2.69M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years0% Under 1 year100%

Quarterly turnover

52.9%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting AIDX on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CA Cresset Asset Management, LLC	240.1K	1.88%	−24.2K (−9.2%)	Q1 '26	0.0%
Shares held by quarter Peak holding264.4K (Q1'26) Change over 8 quarters+240.1K Share of the company1.880% Cresset Asset Management, LLC's full portfolio →
HF HRT Financial LP	89.3K	0.70%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding89.3K (Q2'26) Change over 8 quarters+89.3K Share of the company0.700% HRT Financial LP's full portfolio →

Cresset Asset Management, LLC

240.1K

% of company

1.88%

Change vs last qtr

−24.2K (−9.2%)

Held since

Q1 '26

HRT Financial LP

89.3K

% of company

0.70%

Change vs last qtr

NEW

Held since

Q2 '26

14 more super investors behind a free account

See every manager holding 20/20 Biolabs Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting AIDX on Form N-PORT; together they hold 0.4% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$26.9K	43.6K	0.34%	0.00%	August 31, 2026
FN Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust	$3.28K	5.3K	0.04%	0.00%	August 31, 2026

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$26.9K

% of company

0.34%

% of the fund

0.00%

As of

August 31, 2026

Fidelity Nasdaq Composite Index Fund

Fidelity Concord Street Trust

Position value

$3.28K

% of company

0.04%

% of the fund

0.00%

As of

August 31, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
JM Jonathan M Cohen 5%+ holder 13D · 16.8%	1.8M	14.36%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company14.360% Disclosed stake13D · 16.8% View the 13D/G filing →
RJ Rollins John Woodson Insider	30.3K	0.24%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.240% Rollins John Woodson's insider activity →

Jonathan M Cohen

5%+ holder13D · 16.8%

1.8M

% of company

14.36%

Change vs last qtr

—

Held since

—

Rollins John Woodson

Insider

30.3K

% of company

0.24%

Change vs last qtr

—

Held since

—

3 more holders behind a free account

See every insider and 5%+ holder of 20/20 Biolabs Inc.

Comments